Latest Hana Mining Ltd New (HNMFF) Headlines
Post# of 1
Posted On: 03/10/2014 3:51:32 AM
Latest Hana Mining Ltd New (HNMFF) Headlines
Sanluis Corporacion Sets Date to Release 4th Quarter and 2013 Financial Results
Close-Up Media - Thu Feb 20, 12:19AM CST
Sanluis Corporacion, S.A.B. de C.V., a Mexican industrial company engaged in the design and manufacture of suspension and brake components for the automotive industry, announced that it will release its unaudited financial results for the fourth quarter and fiscal year ended Dec. 31, 2013, on Thursday, Feb. 27.
Dunav Resources Reports Change to the Board of Directors
Marketwire - Thu Feb 13, 2:16PM CST
Dunav Resources Ltd. (TSX VENTURE: DNV) (the "Company") reports that Jonathan Goodman and John Wakeford have resigned as directors of the Company due to other commitments. Management and the board extend their appreciation for their valuable contributions to the Company since 2011.
ICE Canadian Canola Board Margin Index Close
Commodity News Service Canada - Commodity News Service Canada, Inc. - Tue Jan 07, 3:17PM CST
The Canadian Canola Board Margin Index, as posted by ICE Futures Canada, is a formula developed by the members of the Canadian Oilseed Processors Association (COPA).
Fifth Street Senior Floating Rate Corp. Increases Quarterly Dividend by 15%
GlobeNewswire - Tue Jan 07, 3:15PM CST
Fifth Street Senior Floating Rate Corp. (NASDAQ:FSFR) ("FSFR") today announced that its Board of Directors declared a $0.23 dividend per share through March 31, 2014. The March quarterly dividend represents a 15% increase from the prior quarter's dividend of $0.20 per share.
Ewing Sarcoma Global Clinical Trials Review, H2, 2013
M2 - Fri Dec 20, 8:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/2bwbbz/ewing_sarcoma) has announced the addition of the "Ewing Sarcoma Global Clinical Trials Review, H2, 2013" report to their offering. Ewing Sarcoma Global Clinical Trials Review, H2, 2013" provides data on the Ewing Sarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ewing Sarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ewing Sarcoma. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies Participating in Ewing Sarcoma Therapeutics Clinical Trials - Eli Lilly and Company - F. Hoffmann-La Roche Ltd. - Pfizer Inc. - Celgene Corporation - Amgen Inc. - Gradalis Inc. - Daiichi Sankyo Company, Limited - BioMarin Pharmaceutical Inc. Clinical Trial Overview of Top Institutes / Government - National Cancer Institute - Children's Oncology Group - Memorial Sloan Kettering Cancer Center - St. Jude Children's Research Hospital, Inc. - Stanford University - The University of Texas M. D. Anderson Cancer Center - Massachusetts General Hospital - University of Louisville - Dana-Farber Cancer Institute, Inc. - Children's Memorial Hospital For more information visit http://www.researchandmarkets.com/research/2b...ng_sarcoma
Sanluis Corporacion Sets Date to Release 4th Quarter and 2013 Financial Results
Close-Up Media - Thu Feb 20, 12:19AM CST
Sanluis Corporacion, S.A.B. de C.V., a Mexican industrial company engaged in the design and manufacture of suspension and brake components for the automotive industry, announced that it will release its unaudited financial results for the fourth quarter and fiscal year ended Dec. 31, 2013, on Thursday, Feb. 27.
Dunav Resources Reports Change to the Board of Directors
Marketwire - Thu Feb 13, 2:16PM CST
Dunav Resources Ltd. (TSX VENTURE: DNV) (the "Company") reports that Jonathan Goodman and John Wakeford have resigned as directors of the Company due to other commitments. Management and the board extend their appreciation for their valuable contributions to the Company since 2011.
ICE Canadian Canola Board Margin Index Close
Commodity News Service Canada - Commodity News Service Canada, Inc. - Tue Jan 07, 3:17PM CST
The Canadian Canola Board Margin Index, as posted by ICE Futures Canada, is a formula developed by the members of the Canadian Oilseed Processors Association (COPA).
Fifth Street Senior Floating Rate Corp. Increases Quarterly Dividend by 15%
GlobeNewswire - Tue Jan 07, 3:15PM CST
Fifth Street Senior Floating Rate Corp. (NASDAQ:FSFR) ("FSFR") today announced that its Board of Directors declared a $0.23 dividend per share through March 31, 2014. The March quarterly dividend represents a 15% increase from the prior quarter's dividend of $0.20 per share.
Ewing Sarcoma Global Clinical Trials Review, H2, 2013
M2 - Fri Dec 20, 8:32AM CST
Research and Markets (http://www.researchandmarkets.com/research/2bwbbz/ewing_sarcoma) has announced the addition of the "Ewing Sarcoma Global Clinical Trials Review, H2, 2013" report to their offering. Ewing Sarcoma Global Clinical Trials Review, H2, 2013" provides data on the Ewing Sarcoma clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Ewing Sarcoma. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Ewing Sarcoma. Scope - Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations - Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type - Listings of discontinued trials (suspended, withdrawn and terminated) Top Companies Participating in Ewing Sarcoma Therapeutics Clinical Trials - Eli Lilly and Company - F. Hoffmann-La Roche Ltd. - Pfizer Inc. - Celgene Corporation - Amgen Inc. - Gradalis Inc. - Daiichi Sankyo Company, Limited - BioMarin Pharmaceutical Inc. Clinical Trial Overview of Top Institutes / Government - National Cancer Institute - Children's Oncology Group - Memorial Sloan Kettering Cancer Center - St. Jude Children's Research Hospital, Inc. - Stanford University - The University of Texas M. D. Anderson Cancer Center - Massachusetts General Hospital - University of Louisville - Dana-Farber Cancer Institute, Inc. - Children's Memorial Hospital For more information visit http://www.researchandmarkets.com/research/2b...ng_sarcoma
(0)
(0)Hana Mining Ltd New (HNMFF) Stock Research Links
Scroll down for more posts ▼